Profile
ABVC VRTX REGN ALNY SGEN ARGX
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $56.89M $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.02K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Uttam Yashwant Patil Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABVC VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 2
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Sell
Trading
ABVC VRTX REGN ALNY SGEN ARGX
Last Close $3.35 $459.81 $542.52 $320.53 $228.74 $564.59
High 52 $4.76 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.41 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -29.62 % -11.02 % -54.86 % -3.43 % 0 % -15.95 %
Price vs. 52 Week Low 717.07 % 15.93 % 12.34 % 42.72 % 0 % 22.47 %
Total Return
ABVC VRTX REGN ALNY SGEN ARGX
1 Month Return 72.68 % 2.54 % 5.63 % 2.63 % 0 % 4.96 %
3 Month Return 291.81 % -5.99 % -3.67 % 36.65 % 0 % -5.3 %
6 Month Return 520.37 % 8.96 % -20.4 % 30.15 % 0 % -11.85 %
9 Month Return 511.31 % -4.8 % -45.24 % 8.31 % 0 % -0.07 %
YTD Return 467.8 % 14.18 % -23.84 % 36.22 % 0 % -8.2 %
1 Year Return 305.57 % -6.46 % -48.99 % 34.77 % 0 % 19.79 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ABVC VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 99.5 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -12.18 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -31.13 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -23.84 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 77.68 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 119.39 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -384.33 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -75.09 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 0.95 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM 0.22 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 5.41 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 3.42 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.11 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.13 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1.45 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -320.56 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 115.1 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -75.09 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -30.33 -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -30.77 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -30.77 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
ABVC VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 99.85% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.43 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABVC VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
ABVC VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.39
AARD Aardvark Therapeutics, Inc. Common Stock 11.62
ABCL AbCellera Biologics Inc. 4.48
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.59
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.0225
ABSI Absci Corporation 3.12
ABUS Arbutus Biopharma Corporation 3.13
ABVX Abivax SA American Depositary Shares 9.95
ACAD ACADIA Pharmaceuticals Inc. 22.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7595
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.68
ACIU AC Immune SA 2.07
ACLX Arcellx, Inc. 67.59
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 309.09
VXF Vanguard Extended Market Index Fund 0 198.49
IWC iShares Micro-Cap ETF 0 133.64
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 150.58
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 150.59
VEMPX Vanguard Extended Market Index InstlPlus 0 371.61
Unlock